mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.002 |